Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00014300 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

NETWORK

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: glufosfamide

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC